Atopic dermatitis (eczema) trials in United States

In United States 77 Also abroad 251

77 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Where
New York
Age
12 years and over
People
56
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07242638
No phaseTaking people
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Where
Bethesda
Age
3 years to 100 years
People
10,000
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06732414
Phase 3Taking people
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Where
Bakersfield, Birmingham, Dallas, Fargo, Marietta, Miami, Northridge, Panama City, San Diego, Savannah, Scottsdale, Southlake, St. Petersburg, West Hills
Age
12 years and over
People
375 worldwide
Run by
Pfizer
See details and how to joinNCT07765888 · EU 2026-526155-65-00
Phase 4Not yet taking people in United States
AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes
Where
City of Saint Peters, Crest Hill, Fairfax, Grand Rapids, Greensburg, Houston, Libertyville, Mobile, Vienna, Virginia Beach
Age
12 years and over
People
250
Run by
Forefront Dermatology S.C
See details and how to joinNCT07856134
Phase 1Taking people
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Where
Irvine, New York, The Bronx
Age
18 years to 72 years
People
237 worldwide
Run by
Bambusa Therapeutics
See details and how to joinNCT06808477 · EU 2025-522918-23-00
Phase 2Taking people
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Where
Arlington, Atlanta, Birmingham, Brighton, Brooklyn, Cypress, Dallas, Fort Smith, Fountain Valley, Houston, Los Angeles, Louisville, Macon, Miami, Portsmouth, Sacramento, Saint Joseph, San Antonio, Santa Ana, Santa Monica, St. Petersburg, Troy, Washington D.C.
Age
18 years to 100 years
People
224 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00
Phase 3Taking people
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Where
Birmingham, Charleston, Greenville, Indianapolis, Jacksonville, Meridian, North Little Rock, San Antonio, San Diego, St Louis
Age
6 years to 11 years
People
150 worldwide
Run by
Pfizer
See details and how to joinNCT06807268 · EU 2023-509121-51-00
Phase 2Taking people
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Where
Arlington, Atlanta, Auburn Hills, Bay City, Beverly Hills, Birmingham, Camp Hill, Canton, Chicago, Clarksville, Clinton Township, Fort Lauderdale, Fremont, Hot Springs, Houston, Las Vegas, Louisville, Mayfield Heights, Miami, Miramar, New Albany, New York, Norfolk, San Antonio, San Diego, Santa Monica, Warren, West Hills, West Lafayette, Wilmington
Age
18 years to 75 years
People
105
Run by
Enveda Therapeutics
See details and how to joinNCT07298395
Phase 4Taking people
The Impact of Dietary Salt on the Severity of Eczema
Where
San Francisco
Age
18 years and over
People
40
Run by
University of California, San Francisco
See details and how to joinNCT07447063
No phaseNot yet taking people in United States
An Observational Study of Patients With Dermatologic Disease
Where
New York
People
2,000,000
Run by
Target PharmaSolutions, Inc.
See details and how to joinNCT07748169
Phase 4Taking people
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Where
San Francisco
Age
18 years and over
People
50
Run by
University of California, San Francisco
See details and how to joinNCT07487831
Phase 3Taking people
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Birmingham, Columbus, Kirksville, Las Vegas, Lee's Summit, Metairie, Oxnard, Palmdale, Robbinsville, Sacramento, Savannah, Tamarac, The Bronx
Age
12 years and over
People
510 worldwide
Run by
Nektar Therapeutics
See details and how to joinNCT07711418 · EU 2025-525129-11-00
Phase 2/3Taking people
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Where
Irving
Age
18 years to 80 years
People
190
Run by
Turn Therapeutics
See details and how to joinNCT07355075
Phase 4Not yet taking people in United States
Opzelura Experience Study
Where
Winston-Salem
Age
2 years and over
People
50
Run by
Wake Forest University Health Sciences
See details and how to joinNCT07661979
Phase 2Taking people
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Where
Birmingham, Bryant, Camp Hill, Cape Coral, Clarksville, Clifton, Columbus, Fargo, Hollywood, Huntington Beach, Indianapolis, Los Angeles, Meridian, Miami, New York, North Lauderdale, North Miami Beach, Northridge, Pasadena, Phoenix, Pittsburgh, Reno, Sacramento, San Antonio, Savannah, Skokie, Tampa, Tarzana, Wheat Ridge
Age
18 years to 65 years
People
280 worldwide
Run by
Apollo Therapeutics Ltd
See details and how to joinNCT07599813
Phase 2Taking people
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Where
Bethesda
Age
3 years to 21 years
People
200
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03835767
No phaseTaking people
CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Where
Waltham
Age
18 years and over
People
10,000
Run by
CorEvitas
See details and how to joinNCT04504955
No phaseTaking people
PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
Where
Waltham
Age
18 years and over
People
2,000
Run by
CorEvitas
See details and how to joinNCT07598058
No phaseTaking people
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
Where
San Diego
Age
12 years and over
People
150
Run by
Pfizer
See details and how to joinNCT06899204
Phase 2Taking people
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
Where
San Antonio
Age
6 months to 23 months
People
35 worldwide
Run by
Galderma R&D
See details and how to joinNCT07660835 · EU 2025-525027-27-00
Phase 4Taking people
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Where
Sacramento
Age
12 years and over
People
40
Run by
Integrative Skin Science and Research
See details and how to joinNCT07560618
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Where
Anderson, Burien, Charlotte, Columbus, Fargo, Kew Gardens, Lancaster, Los Angeles, Mayfield Heights, New York, Ocala, Portland, Rolling Meadows, Southlake, Tampa, Woodbury
Age
18 years to 74 years
People
405 worldwide
Run by
Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00
Phase 2Taking people
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Where
Boca Raton, Dallas, Encinitas, Indianapolis, Los Angeles, Northridge, Plainfield, San Antonio, Sugar Land
Age
18 years and over
People
200
Run by
Enveda Therapeutics
See details and how to joinNCT07643766
No phaseTaking people
Topical Treatment for Atopic Dermatitis
Where
Winston-Salem
Age
9 years and over
People
30
Run by
Wake Forest University Health Sciences
See details and how to joinNCT06244212
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Where
Anderson, Burien, Charlotte, Columbus, Fargo, Kew Gardens, Lancaster, Los Angeles, Mayfield Heights, New York, Ocala, Portland, Rolling Meadows, Southlake, Tampa, Woodbury
Age
18 years to 75 years
People
400 worldwide
Run by
Inmagene LLC
See details and how to joinNCT07734415